Free Trial
NYSE:NKGN

NKGen Biotech (NKGN) Stock Price, News & Analysis

NKGen Biotech logo
$0.13 0.00 (0.00%)
As of 08/22/2025 03:35 PM Eastern

About NKGen Biotech Stock (NYSE:NKGN)

Key Stats

Today's Range
$0.13
$0.14
50-Day Range
$0.13
$0.33
52-Week Range
$0.10
$0.96
Volume
3,139 shs
Average Volume
1.61 million shs
Market Capitalization
$5.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NKGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NKGen Biotech and its competitors with MarketBeat's FREE daily newsletter.

NKGN Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.tc pixel
See More Headlines

NKGN Stock Analysis - Frequently Asked Questions

NKGen Biotech's stock was trading at $0.6552 at the beginning of 2025. Since then, NKGN shares have decreased by 79.8% and is now trading at $0.1325.

Shares of NKGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that NKGen Biotech investors own include Meta Platforms (META), IonQ (IONQ), Eli Lilly and Company (LLY), NVIDIA (NVDA), Viking Therapeutics (VKTX), Adaptimmune Therapeutics (ADAP) and C3.ai (AI).

Company Calendar

Today
8/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:NKGN
Previous Symbol
NYSE:NKGN
CIK
1845459
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.45)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$82.94 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-479.36%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.02
Quick Ratio
0.02

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($2.68) per share
Price / Book
-0.05

Miscellaneous

Outstanding Shares
44,948,000
Free Float
40,291,000
Market Cap
$5.96 million
Optionable
Not Optionable
Beta
1.19
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NYSE:NKGN) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners